Meyer Handelman Company’s Eli Lilly LLY Stock Holding History

Meyer Handelman Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.9M	Sell	27,119 -706	-3%	-$716K	0.78%	44
2025 Q4	$29.9M	Sell	27,825 -27	-0.1%	-$25.8K	0.94%	36
2025 Q3	$21.3M	Sell	27,852 -477	-2%	-$355K	0.67%	48
2025 Q2	$22.1M	Sell	28,329 -539	-2%	-$419K	0.73%	42
2025 Q1	$23.8M	Sell	28,868 -162	-0.6%	-$135K	0.83%	39
2024 Q4	$22.4M	Buy	29,030 +14	+0%	+$11.6K	0.78%	40
2024 Q3	$25.7M	Sell	29,016 -748	-3%	-$672K	0.87%	38
2024 Q2	$26.9M	Sell	29,764 -380	-1%	-$304K	0.95%	33
2024 Q1	$23.5M	Sell	30,144 -919	-3%	-$654K	0.82%	40
2023 Q4	$18.1M	Hold	31,063	–	–	0.71%	45
2023 Q3	$16.7M	Sell	31,063 -170	-0.5%	-$87.6K	0.67%	48
2023 Q2	$14.6M	Sell	31,233 -300	-1%	-$126K	0.59%	53
2023 Q1	$10.8M	Sell	31,533 -1,000	-3%	-$337K	0.45%	63
2022 Q4	$11.9M	Sell	32,533 -1,275	-4%	-$452K	0.5%	62
2022 Q3	$10.9M	Sell	33,808 -400	-1%	-$127K	0.51%	62
2022 Q2	$11.1M	Sell	34,208 -300	-0.9%	-$90.1K	0.48%	63
2022 Q1	$9.88M	Sell	34,508 -1,900	-5%	-$489K	0.38%	74
2021 Q4	$10.1M	Sell	36,408 -200	-0.5%	-$50.7K	0.37%	74
2021 Q3	$8.46M	Hold	36,608	–	–	0.35%	77
2021 Q2	$8.4M	Hold	36,608	–	–	0.33%	78
2021 Q1	$6.84M	Sell	36,608 -200	-0.5%	-$39.1K	0.28%	84
2020 Q4	$6.21M	Sell	36,808 -650	-2%	-$97K	0.28%	79
2020 Q3	$5.54M	Sell	37,458 -400	-1%	-$61.9K	0.28%	80
2020 Q2	$6.22M	Sell	37,858 -200	-0.5%	-$30.7K	0.33%	73
2020 Q1	$5.28M	Hold	38,058	–	–	0.32%	75
2019 Q4	$5M	Hold	38,058	–	–	0.24%	91
2019 Q3	$4.26M	Hold	38,058	–	–	0.22%	95
2019 Q2	$4.22M	Hold	38,058	–	–	0.22%	96
2019 Q1	$4.7M	Hold	38,058	–	–	0.24%	89
2018 Q4	$4.4M	Hold	38,058	–	–	0.25%	89
2018 Q3	$4.08M	Hold	38,058	–	–	0.2%	99
2018 Q2	$3.25M	Hold	38,058	–	–	0.17%	107
2018 Q1	$2.94M	Sell	38,058 -300	-0.8%	-$24.2K	0.15%	113
2017 Q4	$3.24M	Sell	38,358 -700	-2%	-$59.6K	0.16%	113
2017 Q3	$3.34M	Sell	39,058 -8,725	-18%	-$716K	0.15%	112
2017 Q2	$3.93M	Hold	47,783	–	–	0.17%	104
2017 Q1	$4.02M	Sell	47,783 -250	-0.5%	-$20K	0.17%	104
2016 Q4	$3.53M	Hold	48,033	–	–	0.16%	105
2016 Q3	$3.85M	Hold	48,033	–	–	0.17%	103
2016 Q2	$3.78M	Sell	48,033 -1,275	-3%	-$96K	0.17%	103
2016 Q1	$3.55M	Hold	49,308	–	–	0.16%	106
2015 Q4	$4.16M	Hold	49,308	–	–	0.2%	103
2015 Q3	$4.13M	Hold	49,308	–	–	0.21%	100
2015 Q2	$4.12M	Sell	49,308 -8,000	-14%	-$610K	0.19%	101
2015 Q1	$4.16M	Hold	57,308	–	–	0.19%	101
2014 Q4	$3.95M	Sell	57,308 -1,000	-2%	-$67.5K	0.18%	103
2014 Q3	$3.78M	Hold	58,308	–	–	0.18%	103
2014 Q2	$3.63M	Sell	58,308 -1,960	-3%	-$117K	0.17%	102
2014 Q1	$3.55M	Hold	60,268	–	–	0.17%	102
2013 Q4	$3.07M	Hold	60,268	–	–	0.15%	106
2013 Q3	$3.03M	Hold	60,268	–	–	0.16%	102
2013 Q2	$2.96M	Buy	+60,268	New	+$3.28M	0.16%	102

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Meyer Handelman Company's LLY Position: Q1 2026 in Review

Meyer Handelman Company reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $716K and leaving 27,119 shares worth $24.9M. The position accounts for 0.78% of the portfolio, ranked #44.

Meyer Handelman Company first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.9M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Meyer Handelman Company held 27,119 shares of Eli Lilly worth $24.9M as of Q1 2026.
Meyer Handelman Company sold 706 Eli Lilly shares in Q1 2026, an estimated $716K.
Eli Lilly made up 0.78% of Meyer Handelman Company's portfolio in Q1 2026, its #44 holding.
Meyer Handelman Company first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
Meyer Handelman Company's Eli Lilly position peaked at $29.9M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.